Literature DB >> 28356461

Parental family history of dementia in relation to subclinical brain disease and dementia risk.

Frank J Wolters1, Sven J van der Lee1, Peter J Koudstaal1, Cornelia M van Duijn1, Albert Hofman1, M Kamran Ikram1, Meike W Vernooij1, M Arfan Ikram2.   

Abstract

OBJECTIVE: To determine the association of parental family history with risk of dementia by age at onset and sex of affected parent in a population-based cohort.
METHODS: From 2000 to 2002, we assessed parental history of dementia in participants without dementia of the Rotterdam Study. We investigated associations of parental history with risk of dementia until 2015, adjusting for demographics, cardiovascular risk factors, and known genetic risk variants. Furthermore, we determined the association between parental history and markers of neurodegeneration and vascular disease on MRI.
RESULTS: Of 2,087 participants (mean age 64 years, 55% female), 407 (19.6%) reported a history of dementia in either parent (mean age at diagnosis 79 years). During a mean follow-up of 12.2 years, 142 participants developed dementia. Parental history was associated with risk of dementia independently of known genetic risk factors (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.12-2.48), in particular when parents were diagnosed at younger age (<80 years: HR 2.58, 95% CI 1.61-4.15; ≥80 years: HR 1.01, 95% CI 0.58-1.77). Accordingly, age at diagnosis in probands was highly correlated with age at diagnosis in their parents <80 years (r = 0.57, p = 0.001) but not thereafter (r = 0.17, p = 0.55). Among 1,161 participants without dementia with brain MRI, parental history was related to lower cerebral perfusion and higher burden of white matter lesions and microbleeds. Dementia risk and MRI markers were similar for paternal and maternal history.
CONCLUSIONS: Parental history of dementia increases risk of dementia, primarily when age at parental diagnosis is <80 years. Unexplained heredity may be attributed in part to cerebral hypoperfusion and small vessel disease. We found no evidence of preferential maternal compared to paternal transmission.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28356461     DOI: 10.1212/WNL.0000000000003871

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

2.  The Role of Nutrition and Inflammation on Cognition in a High-Risk Group for Alzheimer's Disease.

Authors:  Jordan M Jackson; Allison A Bay; Jolie Denise Barter; Liang Ni; William Michael Caudle; Monica C Serra; Whitney Wharton; Madeleine E Hackney
Journal:  J Alzheimers Dis Rep       Date:  2020-08-28

3.  Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease.

Authors:  Bessie C Stamm; Patrick J Lao; Batool Rizvi; Juliet Colon; Kay Igwe; Anthony G Chesebro; Benjamin Maas; Nicole Schupf; Richard Mayeux; Jennifer J Manly; Adam M Brickman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

4.  Relationship between Urinary Alzheimer-Associated Neuronal Thread Protein and Apolipoprotein Epsilon 4 Allele in the Cognitively Normal Population.

Authors:  Yuxia Li; Meimei Kang; Can Sheng; Guanqun Chen; Taoran Li; Jun Wang; Yanning Cai; Rong Wang; Ying Han
Journal:  Neural Plast       Date:  2020-06-06       Impact factor: 3.599

5.  Functional and structural connectome properties in the 5XFAD transgenic mouse model of Alzheimer's disease.

Authors:  Shelli R Kesler; Paul Acton; Vikram Rao; William J Ray
Journal:  Netw Neurosci       Date:  2018-06-01

6.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

7.  Uptake and effectiveness of a tailor-made online lifestyle programme targeting modifiable risk factors for dementia among middle-aged descendants of people with recently diagnosed dementia: study protocol of a cluster randomised controlled trial (Demin study).

Authors:  Joyce Vrijsen; Ameen Abu-Hanna; Els Lm Maeckelberghe; Peter Paul De Deyn; Andrea F de Winter; Fransje E Reesink; Richard C Oude Voshaar; Erik Buskens; Sophia E de Rooij; Nynke Smidt
Journal:  BMJ Open       Date:  2020-10-16       Impact factor: 2.692

8.  Association between depression and the risk of Alzheimer's disease using the Korean National Health Insurance Service-Elderly Cohort.

Authors:  Hyunkyu Kim; Wonjeong Jeong; Junhyun Kwon; Youseok Kim; Eun-Cheol Park; Sung-In Jang
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.